Hypolipidaemic Effect of Fenugreek Seeds: a Chronic Study in Non-insulin Dependent Diabetic Patients

The lipid lowering activity of fenugreek seeds ( Trigonella foenum graecum L.) was studied in 60 non-insulin dependent diabetic subjects. Isocaloric diets without and with fenugreek were given for 7 days and 24 weeks respectively. Ingestion of an experimental diet containing 25 g fenugreek seed powder resulted in a significant reduction of total cholesterol, LDL and VLDL cholesterol and triglyceride levels. These results indicate the beneficial effect of fenugreek seeds in diabetic subjects.     

Antidiabetic and hypocholesterolaemic effects of fenugreek

The seeds of Trigonella foenum graecum (fenugreek) have been reported to have antidiabetic and hypocholesterolaemic properties in both animal models and humans. Activity has been attributed largely to fenugreek's saponin and high fibre content, and is probably not related to its major alkaloid trigonelline. Antihyperglycaemic effects have been linked to delayed gastric emptying caused by the fibre content, and to (unidentified) components that inhibit carbohydrate digestive enzymes. Fenugreek administration may increase plasma insulin levels in vivo. Its major free amino acid, 4-hydroxyisoleucine, stimulates insulin secretion from perfused pancreas in vitro. The hypocholesterolaemic effect has been attributed to increased conversion of hepatic cholesterol to bile salts due to loss, in the faeces, of complexes of these substances with fenugreek fibre and saponins. Fenugreek treatment selectively reduces the LDL and VLDL fractions of total cholesterol, and HDL-cholesterol has also been reported to increase in alloxan-induced diabetic rats and type II diabetic individuals following treatment with fenugreek. Fenugreek administration has not been reported to cause any toxicological effects. Its regular consumption may therefore be beneficial in the management of diabetes and the prevention of atherosclerosis and coronary heart disease. © 1998 John Wiley & Sons, Ltd.     

Hypolipidaemic Activity in Rats of Bergenin,the Major Constituent of Flueggea microcarpa

Oral administration of bergenin, isolated from the leaves of Flueggea microcarpa, to hyperlipidaemic rats for 14 days significantly decreased serum total lipid without much change in serum cholesterol and triglycerides. However, after 21 days of administration, the serum cholesterol, triglycerides, low-density lipoprotein (LDL)—and very low-density lipoprotein (VLDL)—cholesterol levels were significantly reduced while the serum high-density lipoprotein (HDL)-cholesterol level was elevated. Bergenin-treated animals also showed a significant decrease in atherogenic index.     

Dietary mucilage promotes regression of atheromatous lesions in hypercholesterolemic rabbits

The antihypercholesterolemic and antiatherogenic effect of the mucilage galactomannan isolated from fenugreek seeds was studied in experimental rabbits maintained on a high cholesterol diet for 3 months. Changes in the levels of cholesterol and triglycerides in serum and tissues and aortic fatty lesions were analysed in animals receiving mucilage (40 mg/kg body weight) daily and compared with the control. A significant decrease in serum total cholesterol, LDL cholesterol and triglycerides and cholesterol and triglycerides in liver and aorta and a decrease in Sudan IV staining of aorta indicated antihypercholesterolemic and antiatherogenic effects of the mucilage. Regression studies showed that administration of mucilage for 3 months caused a significant decrease in serum total and LDL cholesterol and aortic cholesterol. Mucilage accelerated the regression of atheromatous lesions in the aorta as evidenced by significantly low sudanophilic staining. Recovery from inflammation in hypercholesterolemic animals receiving mucilage was evidenced by a faster decrease in C‐reactive protein (CRP) in serum to basal levels. The lipid lowering and antiatherogenic effects of mucilage from fenugreek which is used as a food flavoring spice highlights the importance of dietary intervention in the regression of atherosclerosis. Copyright © 2008 John Wiley & Sons, Ltd.     

Effect of fenugreek consumption on serum lipid profile: A systematic review and meta‐analysis

Various studies have shown that Trigonella foenum‐graecum (fenugreek) supplementation has lipid‐lowering activity. This meta‐analysis was performed to evaluate the effect of fenugreek supplementation on human serum lipid profile. Data sources were PubMed, EMBASE, Scopus, and Coherence library which were searched systematically from January 2000 up to December 2019. Inclusion criteria were randomized clinical trial (RCT) study design, at least one of lipid profile components (triglyceride [TG], total cholesterol [TC], low‐density lipoprotein cholesterol, and high‐density lipoprotein cholesterol) levels measured before fenugreek use and one of the lipid components level reported as result. The pooled weighted mean difference (MD) and its 95% confidence interval (CI) were calculated and pooled using a random‐effect model. Only articles published in English were considered. Fifteen RCTs involving 281 cases consumed fenugreek and 255 control cases in controlled group (11 articles) and 136 cases in uncontrolled group (4 articles) were analyzed in our study. Pooled data of indicated a significant impact of fenugreek supplementation on lowering TC (?1.13 [?1.88, ?0.37]; p = .003), low‐density lipoprotein (LDL) (?1.26 [?2.09, ?0.43]; p = .003), and TG (?1.07 [?1.82, ?0.33]; p = 0.005) and increasing the high‐density lipoprotein (HDL) level (0.70 [0.07, 1.34]; p = .03) compared with the control group. There were no significant differences in TC, TG, and LDL between pre‐ and post‐fenugreek studies in the noncontrolled studies however, the result of combination of four studies without control group showed a significant increase in mean HDL (0.81 [0.33,1.29]; p‐value = .001). The results of subgroup analysis showed that the fenugreek reduced the TG and LDL and increases HDL levels in diabetic subjects more effectively. Fenugreek supplementation significantly improved lipid profile (LDL, TG, TC, and HDL). It could be considered as an effective lipid‐lowering medicinal plant. Further high‐quality studies are needed to firmly establish the clinical efficacy of the plant.     

Effects of fenugreek seeds and its extracts on plasma lipid profile: a study on rabbits

In this study the effect of varying levels of fenugreek were examined on the plasma lipids of animals pretreated with either a control diet or a high-fat diet for 9 weeks. Although the plasma cholesterol was significantly reduced in both groups, triglyceride levels were only reduced in animals pretreated with the high-fat diet. HDL-cholesterol levels were not significantly altered in and case. In addition, the effect of fenugreek seed powder and some of its extracts were investigated for the determination of the active fraction. Fenugreek seed powder and its extracts at 30% of the animals' diet were observed to greatly affect the plasma lipids when added to animals pretreated with a high-fat. Fenugreek and its extracts reduced the levels of cholesterol, triglyceride and LDL-cholesterol with no effect on the HDL-cholesterol. This selective reduction in LDL-cholesterol results in the improvement of the ratio of HDL-cholesterol to LDL-cholesterol which is beneficial in the prevention of atherosclerosis. In addition, the ratio of total cholesterol to HDL-cholesterol was reduced. This hypolipidaemic effect of fenugreek was associated with the defatted fraction of the seed powder, and among the extracts analysed, the crude saponin extract was the most effective fraction with respect to the fenugreek seeds. The improvement of the plasma lipid profile by fenugreek treatment further supports the use of fenugreek seeds as a hypolipidaemic agent in the improvement of lipid disorders. Copyright © 1998 John Wiley & Sons, Ltd.     

Hypolipidaemic and antiatherosclerotic effects of oral Gymnema sylvestre R. Br. Leaf extract in albino rats fed on a high fat diet

Gymnema sylvestre R. Br. leaf extract (25–100 mg/kg) when orally administered to experimentally induced hyperlipidaemic rats for 2 weeks, reduced the elevated serum triglyceride (TG), total cholesterol (TC), very low-density lipoprotein (VLDL)-and low-density lipoprotein (LDL)-cholesterol in a dose-dependent manner. The decreased serum high-density lipoprotein (HDL)-cholesterol and antiatherogenic index (AAI) in hyperlipidaemia were also reversed towards normalization. The ability of this extract (at 100 mg/kg) to lower TG and TC in serum and its antiatherosclerotic potential were almost similar to that of a standard lipid lowering agent—clofibrate.     

Effect of fenugreek seeds on intravenous glucose disposition in non-insulin dependent diabetic patients

The hypoglycaemic activity of fenugreek seeds (Trigonella foenum graecum) in experimental animals and humans has been well documented. Fenugreek has been shown to reduce fasting and postprandial blood glucose levels in diabetic patients. However, it is not clear whether the improvement in glucose tolerance is due to the effect of fenugreek on the absorption or metabolism of glucose. A metabolic study was carried out, and diets with or without 25 g fenugreek were given randomly to 10 non-insulin dependent diabetics, each for 15 days, in a crossover design. An intravenous glucose tolerance test (GTT) at the end of each study period indicated that fenugreek in the diet significantly reduced the area under the plasma glucose curve (AUC), half-life, and increased the metabolic clearance rate. In addition, it increased erythrocyte insulin receptors. These results suggest that fenugreek can improve peripheral glucose utilization which contributes to an improvement in glucose tolerance. Thus, fenugreek may exert its hypoglycaemic effect by acting at the insulin receptor as well as at the gastrointestinal level.     

Hypolipidaemic and antioxidant effect of Enicostemma littorale Blume aqueous extract in cholesterol fed rats

Enicostemma littorale aqueous extract (1.5 g/100 g body weight/day, p.o.) was administered to rats along with hypercholesterolaemic diet for 6 weeks and the hypolipidaemic and antioxidant effect was evaluated. Feeding cholesterol increased serum cholesterol, serum triglycerides, LDL, VLDL and decreased HDL levels as compared to normal diet fed rats. Enicostemma littorale treatment increased HDL levels and decreased serum cholesterol, triglyceride, LDL, VLDL, LDL/HDL ratio. In addition, treatment with the extract showed a decrease in activities of erythrocyte catalase, superoxide dismutase and lipid peroxidation levels, with an increase in reduced glutathione levels as compared to cholesterol fed untreated rats. Liver and kidney cholesterol levels and triglyceride levels were also decreased in Enicostemma littorale treated rats. Hepatic HMG CoA reductase activity was significantly reduced in the extract treated hypercholesterolemic rats. Lovastatin was used as a reference drug. The hypolipidaemic and antioxidant effect of Enicostemma littorale aqueous extract in cholesterol fed rats is being reported for the first time.     

Artichoke leaf extract reduces oxidative stress and lipoprotein dyshomeostasis in rats fed on high cholesterol diet

Hypercholesterolemia and lipid peroxidation play complementary role in atherosclerosis. Artichoke leaf extract (ALE) is rich in natural antioxidants and has a cholesterol‐reducing effect. However, there is no study investigating the effect of ALE on lipid levels and lipid peroxidation in experimental hypercholesterolemic conditions. Rats were fed on 4% (w/w) cholesterol and 1% (w/w) cholic acid supplemented diet for 1 month. ALE (1.5 g/kg/day) was given by gavage during the last 2 weeks. Serum lipid composition, malondialdehyde (MDA) and diene conjugate (DC) levels and plasma antioxidant activity (AOA) were measured. In addition, endogenous DC and copper‐induced MDA levels were determined in apo B‐containing lipoproteins (LDL+VLDL fraction). Serum cholesterol and triglyceride levels and the ratio of cholesterol to HDL‐cholesterol decreased due to ALE treatment in rats fed on HC diet. Significant decreases in serum MDA and DC levels and increases in plasma AOA were detected in serum in ALE‐treated hypercholesterolemic rats. Endogenous DC and copper‐induced MDA levels were also lower in LDL+VLDL fraction due to ALE‐treatment in hypercholesterolemic rats. Our results indicate that ALE may be useful for the prevention of hypercholesterolemia‐induced pro‐oxidant state in LDL+VLDL fraction and the reduction of increased serum cholesterol and triglyceride levels. Copyright © 2009 John Wiley & Sons, Ltd.     

The effects of spirulina on glycemic control and serum lipoproteins in patients with metabolic syndrome and related disorders: A systematic review and meta‐analysis of randomized controlled trials

The aim of this systematic review and meta‐analysis was to evaluate the effects of spirulina on glycemic control and serum lipoproteins in patients with metabolic syndrome (MetS) and related disorders. Two independent authors systematically searched online database including EMBASE, Scopus, PubMed, Cochrane Library, and Web of Science from inception until April 30, 2019. The Cochrane Collaboration's risk of bias tool was applied to assess the methodological quality of included trials. The heterogeneity among the included studies was assessed using Cochrane's Q test and I‐square (I²) statistic. Pooling effect sizes from studies showed a significant reduction in fasting plasma glucose (FPG; weighted mean difference [WMD]: ?10.31; 95% confidence interval, CI [?16.21, ?4.42]) and insulin concentrations (WMD: ?0.53; 95% CI [?0.62, ?0.44]) following the administration of spirulina. Pooled analysis showed also a significant reduction in total cholesterol (WMD: ?20.50; 95% CI [?38.25, ?2.74]), low‐density lipoprotein cholesterol (LDL‐C; WMD: ?19.02; 95% CI [?36.27, ?1.78]), and very low‐density lipoprotein cholesterol (VLDL‐C) concentrations (WMD: ?6.72; 95% CI [?9.19, ?4.26]) and a significant increase in high‐density lipoprotein cholesterol (HDL‐C) levels (WMD: 1.42; 95% CI [0.16, 2.68]) following spirulina therapy. This meta‐analysis demonstrated the beneficial effects of spirulina supplementation on improving FPG, insulin, total cholesterol, LDL‐C, VLDL‐C, and HDL‐C levels in patients with MetS and related disorders.     

Effect of fenugreek seeds on blood lipid peroxidation and antioxidants in diabetic rats

The effect of fenugreek seeds (Trigonella foenum graecum) on blood lipid peroxidation and antioxidant status in alloxan diabetic rats was studied. Increased lipid peroxidation and alterations in circulating antioxidants were observed in the diabetic state. The levels of glutathione, ascorbic acid and β‐carotene in blood were significantly lowered and α‐tocopherol content was increased. Supplementation of fenugreek seeds in the diet lowered lipid peroxidation. The contents of glutathione and β‐carotene were increased and the α‐tocopherol content was lowered. The level of ascorbic acid was unaltered. The level of antioxidants were higher in normal rats which were fed with the fenugreek supplemented diet compared with control animals which were fed commercial rat chow. The study shows that disrupted free radical metabolism in diabetic animals may be normalized by fenugreek seed supplementation in the diet.­Copyright © 1999 John Wiley & Sons, Ltd.     

Hypocholesterolaemic and hypotriglyceridaemic effects of subfractions from fenugreek seeds in alloxan diabetic dogs

The hypocholesterolaemic and hypotriglyceridaemic properties of fenugreek seed subfractions were studied in alloxan diabetic dogs. These subfractions were added to the diet of animals for 21 days. Subfraction a containing testa + endosperm (fibres 79.4%) induced a clear reduction in hyperglycaemia and in elevated plasma cholesterol levels. Subfraction b containing cotyledons + axis (proteins 52.8%, saponins 7.2%) caused a diminution in elevated plasma cholesterol and triglyceride levels. No beneficial effect was observed with subfraction P (proteins 70.50%). Subfraction S (saponins 22.2%) induced, like subfraction b, a reduction in hypercholesterolaemia and hypertriglyceridaemia of the diabetic dogs without inducing significant changes in HDL cholesterol concentrations. Our results show that the hypolipidaemic effects of fenugreek seeds are due to the fraction rich in fibres (hypocholesterolaemic effect) and to the fraction rich in saponins (hypocholesterolaemic and hypotriglyceridaemic effects).     

Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol-fed rabbits

The lipid lowering and antiatherosclerotic effects of Emblica officinalis (Amla) fresh juice were evaluated in cholesterol-fed rabbits (rendered hyperlipidaemic by atherogenic diet and cholesterol feeding). E. officinalis fresh juice was administered at a dose of 5 ml/kg body weight per rabbit per day for 60 days. Serum cholesterol, TG, phospholipid and LDL levels were lowered by 82%, 66%, 77% and 90%, respectively. Similarly, the tissue lipid levels showed a significant reduction following E. officinalis juice administration. Aortic plaques were regressed. E. officinalis juice treated rabbits excreted more cholesterol and phospholipids, suggesting that the mode of absorption was affected. E. officinalis juice is an effective hypolipidaemic agent and can be used as a pharmaceutical tool in hyperlipidaemic subjects.     

Hypolipidaemic activity of seaweed from Karachi coast

During the present study, ethanol extracts of five seaweed species Solieria robusta, Iyengaria stellata, Colpomenia sinuosa, Spatoglossum asperum and Caulerpa racemosa at 10 mg/ 200 g body weight were tested for their hypolipidaemic activity. All the species significantly decreased the serum total cholesterol, triglyceride and low density lipoprotein cholesterol levels in normal, triton-induced and diet-induced hyperlipidaemic rats. Solieria robusta was found to be the most effective in reducing the lipid profile, particularly in diet-induced hyperlipidaemic rats. A beneficial effect of the ethanol extract of S. asperum was also found on cardiac and liver enzymes in diet-induced hyperlipidaemic rats.     

Hypolipidaemic activity of aqueous Ocimum basilicum extract in acute hyperlipidaemia induced by triton WR-1339 in rats and its antioxidant property

Hyperlipidaemia, atherosclerosis and related diseases are becoming a major health problem in developing countries. Ocimum basilicum is one of the medicinal plants widely used in Morocco to reduce plasma cholesterol and to reduce the risk of atherosclerosis-related diseases. However, mechanisms underlying the reported hypolipidaemic effect of this plant have not been investigated. This study evaluates the lipid lowering effect of aqueous Ocimum basilicum extract in Triton WR-1339-induced hyperlipidaemic rats. Hyperlipidaemia was developed in animals by intraperitoneal injection of Triton (200 mg/kg). After injection of Triton the animals were divided into three treatment groups: hyperlipidaemic, hyperlipidaemic plus herb extract and hyperlipidaemic plus fenofibrate treated rats. At 7 h after the Triton injection, levels of plasma cholesterol, triglycerides and LDL-cholesterol in rats treated also with the Ocimum basilicum extract (0.5 g/100 g body weight) were, respectively, 50%, 83% and 79% lower than Triton-treated rats and HDL-cholesterol was 129% higher than in rats given Triton alone. At 24 h following Ocimum basilicum administration, total cholesterol, triglycerides and LDL-cholesterol levels decreased by 56%, 63% and 68%, respectively, in comparison with the Triton treated group and HDL-cholesterol was not increased significantly. The hypolipidaemic effect exerted by Ocimum basilicum extract was markedly stronger than the effect induced by fenofibrate treatments. Further it was demonstrated that Ocimum basilicum aqueous extract displayed a very high antioxidant power. These results indicate that Ocimum basilicum extract may contain hypolipidaemic and antioxidant substances and its use as a therapeutic tool in hyperlipidaemic subjects may be of benefit and encourage further investigation in this field.     

Double-blind cross-over study of modified Anna Pavala Sindhooram in patients with hyperlipidemia or ischemic heart disease

The plasma lipid lowering effect of modified Anna Pavala Sindhooram (APSm) was tested in 30 patients with plasma lipid abnormalities and with symptomatic ischemic heart disease (IHD) in a double-blind cross-over design. HDL2 cholesterol and total HDL cholesterol were increased during APSm therapy leading to a reduction in the coronary risk index. Plasma cholesterol, LDL and VLDL cholesterol, triglycerides, phospholipids and free fatty acids were significantly reduced during APSm therapy while withdrawal of the drug led to a slow increase in these lipids. No adverse side effects were noticed. Some patients were able to reduce their daily doses of antihypertensive and vasodilator drugs during APSm therapy.     

Effect of tomato consumption on fasting blood glucose and lipid profiles: A systematic review and meta‐analysis of randomized controlled trials

Tomato (Solanum lycopersicum) phytochemicals, which include phytoene, phytofluene, beta‐carotene, flavonoids, lycopene, and polyphenols, have been shown to improve the effects of fasting on plasma triglyceride (TG), low‐density lipoprotein cholesterol (LDL), high‐density lipoprotein cholesterol (HDL), total cholesterol (TC), and fasting blood sugar (FBS). The aim of this study was to systematically evaluate the effects of Tomato TC, TG, HDL, LDL, and FBS in humans. A systematic literature search was conducted in PubMed/MEDLINE, Web of sciences, and SCOPUS databases by two researchers for studies published until August of 2019 without language and time limitations. Results were combined with random effect models. Six studies were included in this meta‐analysis. Combined results reveal a significant reduction in cholesterol (weighted mean difference [WMD]: ?4.39 mg/dl, 95% CI: ?7.09, ?1.68, I² = % 48, p heterogeneity: .05), TG (WMD: ?3.94 mg/dl, 95% CI: ?7.67, ?0.21, I² = % 90, p heterogeneity: .001), LDL levels (WMD: ?2.09 mg/dl, 95% CI: ?3.73, ?0.81, I² = % 78, p heterogeneity: .001), and increasing in HDL levels (WMD: 2.25 mg/dl, 95% CI: 0.41, 4.10, I² = % 97, p heterogeneity: .001). Tomato was found to have a higher reduction effect on TG and LDL in younger participants. While pooled results indicate no significant effect on FBS levels (WMD: 0.59 mg/dl, 95% CI: ?0.28, 1.46, I² = % 95, p heterogeneity: .001). In conclusion, the results indicate a significant reduction in total cholesterol, TG, and LDL and increase in HDL levels that is caused by tomato consumption.     

Keishi‐bukuryo‐gan prevents the progression of atherosclerosis in cholesterol‐fed rabbit

In this study, we examined whether in vivo keishi‐bukuryo‐gan (a Kampo formulation) could prevent the progression of atherosclerosis in cholesterol‐fed rabbits, an animal model for hypercholesterolaemia. Sixteen male Japanese white rabbits (2 kg body weight) were divided into two groups. Group A (n = 8) was fed standard rabbit chow containing 1% cholesterol for 8 weeks. Group B (n = 8) was fed standard rabbit chow containing 1% cholesterol and 1% keishi‐bukuryo‐gan for 8 weeks. At the end of the experiment, average plasma concentrations of total‐cholesterol and IDL‐cholesterol were 2055.9 ± 201.8 mg/dL and 408.1 ± 62.6 mg/dL in group A and 1950.5 ± 126.3 mg/dL and 407.6 ± 56.6 mg/dL in group B, respectively. The percentage of the surface area of the total thoracic aorta with visible plaque was significantly reduced by keishi‐bukuryo‐gan administration; group A was 33.2% ± 5.3% and group B was 14.3% ± 2.9%. β ‐very low density lipoprotein (VLDL) and low density lipoprotein (LDL) isolated from cholesterol fed rabbits treated with keishi‐bukuryo‐gan (group B) were shown to be highly resistant to oxidative modification by cupric ion. Sera isolated from rabbits administered keishi‐bukuryo‐gan had reduced lipid peroxide formation compared with those from rabbits without keishi‐bukuryo‐gan. Thus, keishi‐bukuryo‐gan prevents the progression of atherosclerosis in cholesterol‐fed rabbits in vivo by limiting oxidative LDL modification. Copyright © 1999 John Wiley & Sons, Ltd.     

Protective effect of flaxseed oil on renal injury in hyperlipidaemic rats: the effect of flaxseed oil on hyperlipidaemia

This study evaluated the possible effects of flaxseed oil on renal damage associated with hyperlipidaemic rats. Wistar albino male rats were divided into three groups. Group I was fed with a pellet chow. Group II was fed with a high cholesterol diet (HCD) consisting of 5% cholesterol and 0.35% cholic acid added to the pellet chow. Group III was fed with the same HCD, but were orally treated with a dose of 15 mg/kg body wt/day flaxseed oil. Flaxseed oil treatment started 1 week before and continued throughout the 22 weeks of the HCD. At the end of the experiment, renal tissue and blood samples were collected. The biochemical and histopathological findings confirmed renal damage in hypercholesterolaemia conditions. Flaxseed oil reduced the hypercholesterolaemia-induced increase in the serum levels of total cholesterol, LDL and urea. Oil red O stain revealed that lowered serum lipid was accompanied by a decreased deposition of neutral lipid. Flaxseed oil effectively reversed these abnormalities, verifying the protective effects of flaxseed oil in ameliorating renal injuries associated with hypercholesterolaemia.